Source:http://linkedlifedata.com/resource/pubmed/id/16440747
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2006-1-30
|
pubmed:abstractText |
A 34-year-old female was referred to our hospital for the evaluation of atypical lymphocytosis. Leukocyte count at diagnosis was 17,900/microl with 58% atypical lymphocytes having a convoluted nucleus and prominent nucleoli. Because the leukocyte count increased to 43,600/microl, the patient was treated with 2'deoxycoformycin followed by CHOP combination chemotherapy. However, both treatments failed to achieve remission. We planned an allogeneic bone marrow transplantation from an HLA-matched unrelated donor. The patient was treated with Ara-C and etoposide before conditioning to decrease the high leukemia burden. After administration of total body irradiation (12 Gy in six fractions) and cyclophosphamide (total dose of 120 mg/kg) unmanipulated marrow cells were infused. Under prevention of GVHD by CsA and short-term MTX, leukocyte engraft was prompt at day 16, and acute GVHD grade II was observed. Because 9.4% of residual recipient type T-cells was seen with STR analysis on day 22, we decreased the dose of Cs'A. After the occurrence of mild acute GVHD, the residual T-cell number decreased. The patient is still in complete remission for up to 22 months after BMT. We conclude that allogeneic SCT is effective for the treatment of T-PLL.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0485-1439
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
46
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
527-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16440747-Adult,
pubmed-meshheading:16440747-Bone Marrow Transplantation,
pubmed-meshheading:16440747-Combined Modality Therapy,
pubmed-meshheading:16440747-Female,
pubmed-meshheading:16440747-Graft vs Host Disease,
pubmed-meshheading:16440747-Graft vs Leukemia Effect,
pubmed-meshheading:16440747-Humans,
pubmed-meshheading:16440747-Leukemia, Prolymphocytic,
pubmed-meshheading:16440747-Leukemia, T-Cell,
pubmed-meshheading:16440747-Remission Induction,
pubmed-meshheading:16440747-Transplantation, Homologous,
pubmed-meshheading:16440747-Transplantation Conditioning
|
pubmed:year |
2005
|
pubmed:articleTitle |
[Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
|
pubmed:affiliation |
Division of Hematology/Oncology, Department of Medicine, Tokai University School of Medicine.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review,
Case Reports
|